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Supplementary Materials and Methods

Antibodies and reagents
The following antibodies were used for FACS analysis: Fluorescein isothiocyanate (FITC)-conjugated antibodies to mouse CD4 (100510; RM4-5), TCRβ (109206; H57-597), Gr-1 (108406; RB6-8C5) and CD49b (108906; DX5), phycoerythrin (PE)-conjugated antibody to mouse CD8a (100708; 53-6.7), Peridinin-chlorophyll-protein-complex with cyanine dye 5.5 (PerCP-Cy5.5)-conjugated antibodies to mouse CD45.1 (110727; A20), CD4 (100540; RM4-5) and CD44 (103032; IM7), and allophycocyanin (APC)-conjugated antibodies to mouse CD45.2 (109814; 104), CD8a (100712; 53-6.7), CD90.2 (105312; 30-H12) and mouse IgG1 (406609; RM01-1) were all from Biolegend. FITC-conjugated antibodies to mouse CD3ε (553662; 145-2C11), CD8a (553031; 53-6.7), CD11b (553310; M1/70) and mouse IgG1 (553443; A85-1), and Alexa488-conjugated CD45R (557669; RA3-632) and APC-conjugated antibody to mouse IgG1 (560089; A85-1) were all from BD Pharmingen. FITC-conjugated antibody to mouse CD4 (11-0042-81A) and PE-conjugated antibody to mouse CD3ε (12-0031-81; 145-2C11) were from eBioscience. The following antibodies were used for western blotting: anti-pZap70 [Y319] (2719), anti-Zap70 (3165), anti-pLAT [Y191] (3584), anti-LAT (9166) and anti-SLP76 (4985) from Cell Signaling Technology, anti-pSLP76 [Y128] (558367) from BD Pharmingen, anti-mDia1 (610849) from BD transduction, anti-mDia3 (HPA005647) from Sigma-Aldrich, anti-GAPDH (AM4300) from Ambion, HRP-conjugated anti-mouse IgG (NA931V) and HRP-conjugated anti-rabbit IgG (NA934V) from GE Healthcare. The following antibodies were used for immunocytochemistry: anti-mDia1 (610849) from BD transduction, anti-pZap70 [Y319] (2719), anti-pLAT [Y171] (3581), and Alexa555-conjugated anti-pZap70 [Y319] (custom order) from Cell Signaling Technology, Alexa 488-conjugated goat anti-mouse IgG (A11001) from Molecular Probes, and Cy2-conjugated donkey anti-mouse IgG (715-225-151), Cy3-conjugated goat anti-mouse IgG (115-166-003), Cy2-conjugated goat anti-rabbit IgG (111-225-003) and Cy3-conjugated donkey anti-rabbit IgG (711-165-152) from Jackson ImmunoResearch. The following reagents were used for immunocytochemistry: Alexa 488-conjugated Phalloidin (A12379), Alexa 546-conjugated Phalloidin (A22283), Alexa 633-conjugated Phalloidin (A22284) and Hoechst 33342 (H3570) from Molecular Probes. For preparation of the TCR-stimulatory lipid bilayer, dodecahistidine-tagged extracellular domain of ICAM1 (his-ICAM) was purified from the supernatants of High Five cells transfected with a baculovirus expression system using nickel-affinity resin followed by purification on MonoQ and then Superdex FPLC as previously described (23). Biotinylated H-2K b loaded with SIINFEKL peptide (from US National Institutes of Health, Tetramer Facility) was used in monomeric form.
Western blotting
Cells were lysed in Laemmli buffer containing β-mercaptoethanol (21438-82, Nacalai). After sonication and denaturation at 96°C for 5 min, lysates were subjected to SDS-PAGE and the separated proteins then transferred to 0.45-μm PVDF membranes (IPVH304FO, Millipore). The membranes were then blocked in 0.8% membrane blocking agent (RPN2125V, GE Healthcare), probed with the indicated primary antibody, washed and then incubated with HRP-conjugated secondary antibody. Immunoreactivity was detected using ECL prime Western Blotting Detection Reagent (RPN2232, GE Healthcare), and the chemiluminescence signal imaged using a ChemiDoc XRS imaging system (Biorad). Images were processed using Adobe Photoshop CS5 software (Adobe Inc.) and densitometry analysis was performed using ImageJ software (NIH).
Lipid bilayers
Lipid bilayers were prepared as previously described (23). Phospholipid mixtures consisting of 96.5% 1-plamitoyl-2-oleyl-sn-glycerol-3-phosphocholine (POPC), 2% 1, 2-dioleoyl-sn-glycero-3-[(N-(5-amino-1-carboxylpentyl)iminodiacetic acid)succinyl]-nickel-nitrilotriacetic acid (Ni 2+ -NTA-DGS), 1% 1, 2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-cap biotinyl sodium (biotinyl-Cap-PE) and 0.5% polyethylene glycol 5,000-PE (1, 2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000]), all purchased from Avanti Polar Lipids, were mixed in a round-bottom flask and dried. The next day, liposomes were prepared from rehydrated lipid cakes by extrusion through filters (pore size, 100 nm) with a Mini-Extruder set (Avanti Polar Lipids, 610000). For the setup of lipid bilayers, dilutions of liposomes were applied to a rigorously cleaned Lab Tek II chambered cover-glass (155409, Nalge Nunc). Excess liposomes were rinsed away, and bilayers were then blocked in 1% BSA/PBS. Streptavidin in 1% BSA/PBS was loaded onto the cover-glass and then the excess streptavidin was washed away. Biotinylated pMHC and his-ICAM were then loaded onto bilayers at a concentration of 25 ng/ml and 250 ng/ml, respectively. After protein loading, bilayers were rinsed and pre-warmed to 37°C before application of cells. Unless indicated otherwise, 'stimulatory lipid bilayer (SLB)' refers to a bilayer loaded with his-ICAM and pMHC under conditions that generate protein presentation similar to those generated by BMDCs pulsed with 100 ng/ml SIINFEKL peptide.
Quantitative reverse transcription-polymerase chain reaction (qRT-PCR)
mRNA was purified from naïve CD8 T cells using Reliaprep (Promega), and reverse-transcribed to cDNA using PrimeScript RT Master Mix (TaKaRa). cDNA, primers, and SYBR Premix ExTaq (Tli RNaseH Plus, TaKaRa) were mixed in 96-well PCR plates, and quantitative PCR was performed using a CFX96 Real-Time System (Bio-Rad). qRT-PCR data were analyzed using the ΔΔCT method. Primers used were as follows:
ELISA An IL2 ELISA kit (Biolegend, 431004) was used to measure levels of mouse IL2 in cell culture supernatants according to the manufacturer's protocol.
Proliferation assay
Naïve CD8 T cells were plated in 96-well plates at 10 5 cells/well. Plate-bound anti-CD3 (1, 2, 4, 10 μg/ml) and soluble anti-CD28 (2 μg/ml) antibodies were used for TCR stimulation. Cell proliferation rate was assayed using a nonradioactive cell proliferation assay kit (Promega, G358A). Briefly, assays were performed by adding 20 μl of CellTiter 96 Aqueous One Solution Reagent (MTS:[3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazoli um]) in 100 μl medium directly to each well, and the cells then cultured for a further 4 h at 37°C under 5% CO 2 . The MTS compound is bioreduced by cells into a colored formazan product that is soluble in culture medium and this was quantified by measuring the absorbance at 490 nm using a 96-well plate reader (Molecular Devices).
FACS analysis
For surface staining, single-cell suspensions from mouse thymus, spleen or peripheral blood were incubated with anti-CD16/CD32 antibody (553142, BD Pharmingen) for 10 min, stained with indicated mAbs for 30 min on ice, washed and then resuspended in FACS buffer (PBS containing 0.1% bovine serum albumin and 0.1% sodium azide). For intracellular staining of mDia1, cells were fixed and permeabilized using BD Cytofix/Cytoperm solution (554722, BD Biosciences), washed with BD Perm/Wash buffer (554723, BD Biosciences) and then labeled with mDia1 antibody for 1 h at room temperature or 4°C overnight. Quantitative flow cytometry data were acquired on a FACS Calibur (BD Biosciences) or LSR Fortessa (BD Biosciences) system and analyzed using FlowJo software (Tree Star Inc.).
Histology
After subjecting mice to deep anesthesia, the thymus was rapidly removed and fixed in 0.1 M sodium phosphate, pH 7.4, containing 4% paraformaldehyde. The thymus was then embedded in paraffin and cut into sections of 5-μm thickness. Hematoxylin and eosin (H&E) staining was performed using a standard protocol. Bright field images were acquired using an upright BX-50 microscope (Olympus) equipped with a color CCD camera (Optronics). Images were assembled with Stereo Investigator software (MBF Bioscience) and processed using Adobe Photoshop CS5 software (Adobe Inc.).
Bone marrow transplantation
For the transplantation of CD45.2 WT or mDia1/3 DKO donor bone marrow cells to CD45.1 recipients, CD45.1 congenic recipients were lethally irradiated at 9.5 Gy for 11 min before receiving 1 × 10 7 WT or mDia1/3 DKO bone marrow (BM) cells by intravenous injection. In the reverse setting, WT or mDia1/3 DKO mice were lethally irradiated before receiving CD45.1 congenic BM cells. BM chimeras were analyzed at 8 weeks after BM transplantation. OT-I T cells stimulated on a SLB for 10 min (control), or naïve CD8 OT-I T cells stimulated on a SLB for 10 min and then cultured for 5 min in the absence (control+vehicle) or presence (control+SMIFH2) of 15 μM SMIFH2 before fixation. Data are from three experimental replicates. n.s., not significant (one-way ANOVA with post hoc test).
Fig. S2. TCR signaling in naïve CD8 T cells from mDia1 KO or mDia3 KO mice. (A) Western blotting analysis of total protein and pZap70 [Y319] and pLAT [Y191] in lysates of naïve CD8 T cell from control WT and mDia1
KO mice unstimulated (0) or stimulated for 1.5, 3 or 10 min with anti-CD3 (10 μg/ml) and anti-CD28 (2 μg/ml) antibodies. Data are representative of three independent experiments. (B) Densitometric quantification of the western blotting data in A. The value for the phosphorylated form relative to the total protein was normalized by the value obtained for unstimulated control cells. (C) Western blotting analysis of total protein and pZap70 [Y319] and pLAT [Y191] in lysates of naïve CD8 T cells from control WT and mDia3 KO mice unstimulated (0) or stimulated for 1.5, 3 or 10 min with anti-CD3 (10 μg/ml) and anti-CD28 (2 μg/ml) antibodies. Data are representative of three independent experiments. (D) Densitometric quantification of the western blotting data in C. The value for the phosphorylated form relative to the total protein was normalized by the value of obtained for unstimulated control cells. Numbers below each lane indicate densitometric quantification of mDia1 and mDia3 levels relative to GAPDH and normalized to the value obtained for control mDia1/3 double-floxed cells. Data are representative of three independent experiments. (D) FACS analysis of mDia1 protein expression in control and mDia1/3 cDKO thymocytes. The dashed horizontal bar indicates the population of cDKO thymocytes negative for mDia1 expression (94.1% of total thymocytes). (E) CD4 and CD8 surface expression in control and mDia1/3 cDKO thymocytes from 10 to 14-week old mice. Numbers in the outlined regions indicate the percentage of CD4 and CD8 SP thymocytes. (F) Quantification of total, DN, DP, CD4+CD8int DP, CD4 SP or CD8 SP thymocyte subpopulations in mDia1/3 cDKO thymus. Results from eight control mice and seven mDia1/3 cDKO mice are shown, Bars represent mean + SEM. n.s., not significant; **P < 0.01, ***P < 0.001 (Student t-test). 
